EP3368507
Ný lípíð og lípíð-nanóagnasamsetningar til dreifingar á kjarnsýrum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.10.2016EP published:
7.12.2022EP application number:
16794175.6
EP translation filed:
20.2.2023Grant published:
15.3.2023EPO information:
European Patent Register
Max expiry date:
27.10.2036Expiry date:
27.10.2026Next due date:
31.10.2026
Title in English:
NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDSLanguage of the patent:
English
Timeline
Today
28.10.2016EP application
7.12.2022EP Publication
20.2.2023Translation submitted
15.3.2023Registration published
27.10.2026Expires
Owner
Name:
Acuitas Therapeutics Inc.Address:
6190 Agronomy Road Suite 402 University of British Columbia - KETR, Vancouver, British Columbia V6T 1W5, CA
Inventor
Name:
ANSELL, Steven, M.Address:
Vancouver, British Columbia V6J 1W5, CA
Name:
DU, XinyaoAddress:
Richmond, British Columbia V7A 2M1, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562247616 PDate:
28.10.2015Country:
US
Number:
201662328244 PDate:
27.4.2016Country:
US
Classification
Categories:
C07C 219/06, C07C 229/16, C07C 233/18, C07C 255/24, A61K 9/127, C12N 15/11, A61K 47/18, C12N 9/02
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 19.10.2023
Expires: 27.10.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.10.2024
Expires: 27.10.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 16.10.2025
Expires: 27.10.2026
Payer: Árnason Faktor ehf.